首页> 外文期刊>Journal of cardiovascular electrophysiology >Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.
【24h】

Genetic basis of hypertrophic cardiomyopathy: from bench to the clinics.

机译:肥厚型心肌病的遗传基础:从实验台到诊所。

获取原文
获取原文并翻译 | 示例
           

摘要

Hypertrophic cardiomyopathy (HCM) is a common inherited cardiac disorder that characterized by marked thickening of the left ventricular wall that occurs in the absence of increased external load. HCM is the most common cause of sudden cardiac death under 35 years and in addition causes heart failure. HCM is usually inherited as an autosomal dominant mutation in genes that encode protein constituents of the sarcomere. To date, more than 450 different mutations have been identified within 13 myofilament-related genes. This review focuses current research involved in the discovery of other causative genes, investigation of the mechanisms by which sarcomere genes mutations produce hypertrophy and arrhythmia, and identification of modifying factors that influence clinical expression in HCM patients. The clinical implications of molecular advances in HCM are discussed.
机译:肥厚性心肌病(HCM)是一种常见的遗传性心脏病,其特征是在没有增加外部负荷的情况下发生的左心室壁明显增厚。 HCM是35岁以下猝死的最常见原因,此外还会导致心力衰竭。 HCM通常在编码肌节蛋白成分的基因中作为常染色体显性突变遗传。迄今为止,已在13条与肌丝相关的基因中鉴定出450多种不同的突变。这篇综述的重点是当前的研究,包括发现其他致病基因,研究肌节基因突变引起肥大和心律不齐的机制以及鉴定影响HCM患者临床表达的修饰因子。讨论了分子生物学在HCM中的临床意义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号